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Abstract
Diabetes is associated with higher incidence of myocardial infarction (MI) and increased propensity for subsequent events
post-MI. Here we conducted a temporal analysis of the influence of diabetes on cardiac dysfunction and remodeling after
ischemia reperfusion (IR) injury in mice. Diabetes was induced using streptozotocin and IR performed by ligating the left
anterior descending coronary artery for 30 min followed by reperfusion for up to 42 days. We first evaluated changes in
cardiac function using echocardiography after 24 hours reperfusion and observed IR injury significantly decreased the
systolic function, such as ejection fraction, fractional shortening and end systolic left ventricular volume (LVESV) in both
control and diabetic mice. The longitudinal systolic and diastolic strain rate were altered after IR, but there were no
significant differences between diabetic mice and controls. However, a reduced ability to metabolize glucose was observed
in the diabetic animals as determined by PET-CT scanning using 2-deoxy-2-(18F)fluoro-D-glucose. Interestingly, after
24 hours reperfusion diabetic mice showed a reduced infarct size and less apoptosis indicated by TUNEL analysis in heart
sections. This may be explained by increased levels of autophagy detected in diabetic mice hearts. Similar increases in IR-
induced macrophage infiltration detected by CD68 staining indicated no change in inflammation between control and
diabetic mice. Over time, control mice subjected to IR developed mild left ventricular dilation whereas diabetic mice
exhibited a decrease in both end diastolic left ventricular volume and LVESV with a decreased intraventricular space and
thicker left ventricular wall, indicating concentric hypertrophy. This was associated with marked increases in fibrosis,
indicted by Masson trichrome staining, of heart sections in diabetic IR group. In summary, we demonstrate that diabetes
principally influences distinct IR-induced chronic changes in cardiac function and remodeling, while a smaller infarct size
and elevated levels of autophagy with similar cardiac function are observed in acute phase.
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Introduction
Diabetes is associated with a higher incidence of heart failure
and cardiac ischemic events [1]. Patients with both type 1 and type
2 diabetes have a higher risk for encountering sudden death
attributed to acute myocardial infarction (MI) and these
individuals also exhibit higher mortality rate and risk for
developing left ventricular dysfunction after MI [2,3]. Although
the adverse influence of diabetes on left ventricular dysfunction is
now a well established phenomenon, the precise temporal nature
and mechanisms responsible are still incompletely understood.
Due to inherent difficulties in analysis of human myocardium,
much of our knowledge on disease mechanisms comes from
animal models showing structural, functional or mechanistic
characteristics that are observed commonly in diabetic hearts
[4,5,6]. Use of rodents to examine the influence of diabetes on
development and progression of cardiomyopathy has been studied
in various transgenic and knockout models in vivo, in isolated
perfused hearts and papillary muscles, or in vitro using isolated
cardiomyocytes [4,5]. However, many paradoxical observations
exist and there is a need for comparative analysis of remodeling
events during the progression of heart failure.
Cardiac remodeling is a progressive process involving changes in
hypertrophy, cardiomyocyte apoptosis, inflammation, cardiac me-
tabolism and fibrosis [6]. Each of these is altered in a time-dependent
fashion subsequent to ischemia reperfusion injury (IR) that occurs
during acute MI. Distinct remodeling events may initially be
beneficial as they are initiated to compensate for failing cardiac
function but remodeling will ultimately cause transition to heart
failure over time [6]. Changes in myocardial metabolism with a
reduced glucose uptake and oxidation and thus even higher reliance
on fatty acids as a source of energy is one of the first observable
remodeling events, often preceding functional indications of a failing
heart [4,6]. Although diabetes has been shown to be associated with
increased incidence of acute MI and poorer clinical outcome after
IR, the specific effects of diabetes on cardiac function and
remodeling, as well as underlying mechanisms, after IR are unclear.
Therefore, we designed this study to conduct a time dependent (up to
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6 weeks) progressive analysis of IR-induced changes in cardiac
performance in control and diabetic mice. We used the streptozot-
ocin-induced diabetic mouse model and induced IR by ligating the
left anterior descending coronary artery. The remodeling events
underlying changes in cardiac function observed at various times
during the course of our study were also investigated.
Materials and Methods
Generation of diabetic animals
Ethics statement. All animal work must have been
conducted according to relevant national and international
guidelines. The protocols used were approved by Institut Pasteur
Korea Animal Care Committee with reference #IPK11005.
Diabetes was induced in male C57BL6 mice (aged 8–10 weeks) via
a single dose intraperitoneal injection of 150 mg/kg streptozotocin
(Sigma, St. Louis, MO) in 0.1 M citrate buffer, pH 4.1 given one
week prior to surgery. Control animals received the citrate buffer
for vehicle treatment. In every case we confirmed the blood
glucose levels of mice at the time of surgert with the following data
obtained: control 143.7765.89 mg/dL and STZ-treated
501.79614.06 mg/dL.
Induction of cardiac ischemia reperfusion injury
The cardiac ischemia reperfusion injury surgery was performed
1 week after the injection of STZ or vehicle solution. The mice
were lightly anaesthetized with Zoletil 50 (10 mg/kg) and
Rompun (2.5 mg/kg) for intubation with a ventilation tube and
they were seduced deeply with an additional 1.5% isofluorane.
Left thoracotomy was performed between the fourth and fifth ribs
and the pericardial tissue was removed before the ligation of LAD
artery. LAD artery was ligated with 7-0 suture around a PF-10
tubing for 30 min and reperfused for 24 hours or 6 weeks. Sham-
operated animals underwent the same surgical procedure except
that the suture was not tied around the LAD artery. Infarct area
was determined by staining the heart sections in 1% 2,3,5-
triphenyltetrazolium chloride (TTC, Sigma) solution. Infarct area
was calculated as % non-TTC-stained area/total ventricular
area.
Determination of apoptotic cells in cardiac tissue
Apoptotic cells were visualised by TUNEL staining of frozen
heart sections using In Situ Cell Death Detection Kit, Fluorescein
(Roche) according to the manufacturer’s protocol. The quantifi-
cation of the number of apoptotic cells was performed using an
image mining algorithm developed in-house.
Protein expression determination using Western blotting
Hearts isolated from the animals were snap-frozen and
homogenized in homogenization buffer (20 mM Tris-HCl
pH 7.5, 150 mM NaCl, 1 mM Na2EDTA, 1 mM EGTA, 1%
Triton, 2.5 mM sodium pyrophosphate, 1 mM b-glycerophos-
phate, 1 mM Na3VO4, 1 ug/ml leupeptin, 1 mM PMSF
supplemented with protease inhibitor cocktail (Sigma-Aldrich)).
Protein samples (40 ug) were run on SDS-PAGE and transferred
onto polyvinylidene fluoride membrane. The membranes were
then probed with primary antibodies against LC3B (Cell
Signaling), Cathepsin D (H-75), p62 (Sigma-Aldrich), and a-
tubulin (P-16, Santa Cruz Biotechnology).
Echocardiography
Images were obtained using Vevo2100 (Visual Sonics,
Toronto, Canada) equipped with MS550D transducer. The mice
were lightly anaesthetized using 1.5% isofluorane and restrained
on a heated imaging table. The four limbs were attached to the
ECG electrodes and hair on the chest was removed using Nair.
Images were obtained from the B-mode parasternal long axis
view, M-mode of the parasternal short-axis view and the pulse
wave Doppler on the mitral valve from the apical four-chamber
view to calculate the cardiac diastolic and systolic functions. The
echocardiography analysis on animals was performed every week
Table 1. Echocardiographic measurements 24 hours after IR.
VEH STZ
sham IR sham IR
HR 446.1615.8 453.769.8 397.0617.8 395.6619.8
LVEDV (ul) 79.363.4 79.862.8 72.962.6 73.862.8
LVESV (ul) 38.163.9 52.464.1* 35.562.4 46.363.3*
EF (%) 52.663.6 38.263.9* 51.362.8 37.463.4*
FS (%) 27.062.3 18.762.0* 26.061.7 18.161.8*
Radial
Systolic strain (%) 17.263.2 9.161.3* 18.260.6 15.461.2**
Diastolic strain (%) 21.560.6 21.460.5 21.3 0.7 21.760.5
Systolic strain rate (/s) 5.360.1 3.660.3* 4.760.4 5.460.5**
Diastolic strain rate (/s) 25.660.4 24.360.5* 24.560.5 24.861.0
Longitudinal
Systolic strain (%) 212.761.2 26.560.7* 212.661.0 28.860.8*
Diastolic strain (%) 0.760.2 1.860.4* 0.860.2 1.260.3
Systolic strain rate (/s) 24.060.2 22.960.3* 24.260.2 23.760.3
Diastolic strain rate (/s) 4.360.2 3.360.4* 4.360.6 3.360.3*
*p,0.05 when compared to its own sham.
**p,0.05 when compared to VEH IR.
doi:10.1371/journal.pone.0030450.t001
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starting 24 hr after the surgery up to 6 weeks. Echocardiograms
were stored digitally and strain rate analysis were performed with
Vevostrain software (Visual Sonics, Toronto, Canada). All
parameters were averaged over at least three cardiac cycles.
For quantitative analysis of global left ventricular systolic
function, peak systolic strain and systolic strain rate at 6 segments
were obtained and the average values were calculated. For
quantitative analysis of global diastolic function, peak diastolic
strain rate at 6 segments were obtained and the average values
were calculated.
PET imaging and analysis
Whole-body [18F]FDG PET/CT was performed using an
animal PET/CT scanner (eXplore Vista DR PET/CT, GE
Healthcare, Milwaukee, WI). The mice were maintained under
fasting condition for 12–14 hours. Thirty minutes before the
[18F]FDG injection, the animals were treated with oral-
administration of glucose (10 mg/g body weight) using zonde to
enhance tracer uptake into the myocardium. The PET/CT
imaging acquisition was initiated 30 min after the introduction of
18.5 MBq/0.1 mL of [18F]FDG via the tail vein injection. Mice
Figure 1. Echocardiography analysis was performed to examine the cardiac function after IR injury. IR injury (30 min) caused a
significant decrease in EF in both VEH and STZ animals but no difference was observed between the two IR groups (A). Representative M-mode
images from each group where the numbers used for calculations were derived (B). The calculated systolic strain (C), diastolic strain (D), systolic strain
rate (E), and diastolic strain rate (F) are derived from cardiac strain analysis. n$10/group and * indicates that p,0.05 compared to sham of the same
treatment group. ** indicates that p,0.05 compared to VEH IR. All values are expressed as absolute values.
doi:10.1371/journal.pone.0030450.g001
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were maintained under isoflurane anesthesia (2% in 100%
oxygen) on a heating pad during the injection of [18F]FDG,
uptake period, and PET/CT scanning. Static whole-body PET
scans were performed during 10 min in 2 frames. CT scan
(40 kV, 250 mA) was obtained during 11.5 min in 2 frames. The
images were obtained by Fourier rebinning using ordered subsets
expectation maximization (OSEM) reconstruction algorithm with
decay-correction, attenuation-correction and random-correction
from raw framed sinograms. The data were reconstructed over a
17561756118 matrix with 0.77-mm slice thickness. Processed
images were displayed in coronal, transverse and sagittal planes.
For each PET scan, 3-dimensional regions of interest (ROI) were
drawn over heart region on whole-body axial images. The
standardized uptake value (SUV) for the calibrated and decay
corrected series representing 3-D volume data was done as
follows: SUV=ROI activity (MBq/g)/[injected dose (MBq)/
body weight (g)].
Histology
The degree of fibrosis was examined by staining frozen heart
sections for collagen using Masson Trichrome method. Quanti-
fication of the blue area representing collagen was performed as
previously described [7] using the Photoshop software. The
number of macrophages infiltrating the heart was identified using
antibody against CD68 (FA-11, Serotec) and quantified using an
in-house image analysis software developed by Dr. Thierry Dorval
(Institut Pasteur Korea).
Statistics
All data are expressed as the means 6 SEM. Statistical analysis
was performed using t-test or one-way ANOVA and differences
were determined to be statistically significant when P,0.05.
Results
Overall Cardiac function 24 h after IR injury in Diabetic
mice
Echocardiography analysis at 24 hours reperfusion revealed
that IR injury significantly decreased the systolic function in both
vehicle treated non-diabetic (VEH) mice and STZ treated diabetic
(STZ) mice (table 1 and figure 1). Both ejection fraction (EF) and
fractional shortening were significantly reduced in both STZ and
VEH animals after IR injury. End systolic left ventricular volume
(LVESV) was also increased without any increase in end diastolic
Figure 2. 18FDG PET-CT was used to examine the level of cardiac glucose uptake in VEH and STZ mice at 24 hr reperfusion.
Representative scan images from transverse view (A) and other views (B) from each group are shown. The higher glucose uptake level is shown as the
increase in the intensity of red as indicated on the color scale bar shown in each image. Quantification of the accumulated 18FDG (n$4) in the heart
shows that STZ heart has a significantly decreased glucose uptake level (C). * indicates that p,0.05 compared to VEH.
doi:10.1371/journal.pone.0030450.g002
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left ventricular volume (LVEDV), further indicating a decrease in
the left ventricular (LV) contractility. In both groups, the decrease
in EF comes from decreased contractility of the anterior wall
(figure 1A,B). VEH mice showed a decrease in both radial and
longitudinal systolic strain and strain rate whereas STZ mice
showed a decrease only in longitudinal systolic strain (table 1,
figure 1C&E). VEH mice showed an increase in longitudinal
diastolic strain but a decrease in both radial and longitudinal
diastolic strain rate, all of which were not affected in STZ mice
after IR (figure 1D&E).
Cardiac glucose uptake after IR is reduced in diabetic
mice
In order to examine the level of cardiac glucose metabolism
after IR injury in VEH and STZ mice, 18FDG was used to analyze
the level of glucose uptake by the heart at 24 hours of reperfusion
period. 18FDG PET-CT method has been used widely in
experimental and clinical settings to quantify cardiac glucose
metabolism in the heart [8]. When quantified, total 18FDG uptake
by the heart was significantly reduced in STZ mice compared to
VEH mice (figure 2).
Figure 3. Effects of IR injury on cardiac cell death. A) Hearts were isolated at 24 hr of reperfusion and stained with TTC for the measurement of
infarct area. Viable part of the heart appears red and the infarct area white. B) Quantification of the infarct area shows that the infarct area is
significantly smaller in STZ compared to VEH hearts. C) Apoptotic cells were identified using TUNEL method. TUNEL-positive nuclei are shown in
green and total nuclei in DAPI, blue. D) Quantification of TUNEL positive nuclei reveals that the number of apoptotic cells is much lower in the hearts
isolated from STZ animals. Analysis of autophagy-related proteins (E) indicates that autophagy is upregulated in STZ heart. The level of LC3II was
significantly higher in the STZ heart compared to VEH and the increase in autophagy was confirmed by the increase in cathepsin D and decrease in
p62. (n$3) and * indicates that p,0.05 compared to VEH.
doi:10.1371/journal.pone.0030450.g003
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Infarct size induced by IR is smaller in diabetic mice
To examine the effects of STZ-diabetes on the extent of
myocardial injury induced by IR, isolated hearts were stained with
TTC to identify the infarct area size. Infarct area was significantly
reduced in STZ animals compared to VEH animals at 24 hours of
reperfusion time as shown visually and quantitatively in figure 3A
and B, respectively. We also studied the extent of cell death using
TUNEL staining of heart sections prepared after 24 hours of
reperfusion. Consistent with infarct area data, the number of
apoptotic cells was significantly lower in the STZ mouse heart
compared to VEH (figure 3C,D).
Autophagy is upregulated in diabetic mice hearts
To assess the degree of autophagy in mouse heart, whole tissue
homogenate samples were run on Western blot to examine LC3I/
II protein level, which is a commonly used marker to determine
the extent of autophagy [9]. We observed that STZ-diabetic hearts
showed an increased level of LC3II protein (figure 3E), suggesting
the upregulation of autophagosome formation. The upregulation
of autophagy was further indicated by alterations in expression of
cathepsin D and p62 (figure 3E).
IR-induced macrophage infiltration is not affected by
diabetes
Macrophage infiltration is part of the local inflammatory
response following myocardial infarction and here we examined
this process in VEH or STZ mice subjected to IR by staining for
the macrophage marker CD68 (figure 4). IR injury increased the
number of macrophages recruited into the infarct area to a similar
extent in VEH and STZ animals.
Diabetes leads to distinct progressive changes in cardiac
function over time
Over the 6 weeks period that the study was carried out, VEH
mice showed a small but significant increase in end diastolic left
ventricular volume (LVEDV) (figure 5A). These mice also
exhibited a tendency to increase LVESV (figure 5B) but this
increase was not statistically significant. STZ animals on the other
hand exhibited a decrease in both LVEDV and LVESV.
Importantly, diabetic mice also showed an increase in ejection
fraction after IR (figure 5C). STZ mice also developed at 42 days a
decreased intraventricular space and thicker left ventricular wall
suggesting the development of concentric hypertrophy
(figure 5D,E).
Diabetes enhances interstitial collagen deposition after
IR injury
Fibrosis resulting from collagen deposition was detected using
Masson trichrome staining in sections from hearts isolated at 6
weeks post-IR injury (figure 6A,B). Our data revealed an increased
level of interstitial collagen deposition in the remote area. STZ-
diabetes in sham animals had no effect on the degree of fibrosis,
yet the level of collagen deposition was significantly higher in STZ
mouse heart after IR compared to VEH heart (figure 6A,B).
Discussion
Cardiac remodeling is a progressive and dynamic process
composed of multiple components that show distinct temporal
changes [4,5,6]. As mentioned previously, the current literature
contains many apparently paradoxical observations on the
contribution of diabetes to various remodeling events after the
induction of IR. Various explanations are plausible, such as
coexistence of obesity, lipotoxicity, activation of renin-angiotensin
system and cardiac insulin resistance [4]. Furthermore, we believe
one principal factor is that studies were often conducted at a
particular time point and although such studies are individually
interesting, they neglect the extremely important progressive
nature of cardiac remodeling. Here we studied the temporal
changes in cardiac structure and function after IR in the non-
diabetic and STZ-induced diabetic mouse model and also
examined the significance of distinct remodeling events in relation
to these changes. The use of the single high-dose STZ injection
model was chosen here primarily to address the consequences of
hyperglycemia and lack of insulin on cardiac remodeling. It would
also be interesting to conduct similar studies in other commonly
used obese and diabetic mouse models, in particular high fat diet,
although many of these are associated with too many confounding
factors in addition to hyperglycemia.
We initially focused on myocardial structural and functional
alterations determined using echocardiography. Speckle tracking
strain analysis is a novel method which permits the assessment of
myocardial deformation in 2 dimensions [10]. In subjects with
myocardial infarction, longitudinal strains are significantly re-
duced proportionately within the area of infarction, and correlate
closely with peak infarct mass and ejection fraction. Hearts with
smaller infarcts and preserved global left ventricular ejection
fraction show sustained radial and longitudinal strain. Therefore,
parameters from speckle tracking analysis are regarded as more
Figure 4. Macrophage infiltration into the heart was examined by immunofluorescent microscopy for macrophage marker CD68.
Representative images taken from each group showing the presence of CD68 as red fluorescent (A). Quantification of the number of macrophages in
defined area (B). No difference was observed between the VEH and STZ heart at 24 hr of reperfusion. n = 5 and * indicates that p,0.05 compared to
sham of the same treatment group.
doi:10.1371/journal.pone.0030450.g004
Temporal Cardiac Remodeling in Diabetes
PLoS ONE | www.plosone.org 6 February 2012 | Volume 7 | Issue 2 | e30450
sensitive than simple conventional echocardiographic parameters
to detect myocardial dysfunction [10]. In our study, despite similar
reduction of left ventricular ejection fraction after IR, the diabetic
group revealed a smaller reduction of radial and longitudianal
strain than control group. These findings were consistent with a
smaller infarct area in diabetic IR group.
Changes in cardiac metabolism are one of the most important
early events in development of cardiomyopathy [4,6]. Diabetic
models consistently demonstrate increased fatty acid utilization
and decreased glucose utilization, and the increased use of fatty
acid oxidation as a source of ATP generation in the diabetic heart
is associated with a higher oxygen consumption which leads to
increased oxidative stress and decreased cardiac efficiency [11].
These changes in cardiac metabolism during reperfusion period
can have a significant effect on the function of the heart after IR
injury [12,13]. Furthermore, the STZ-induced diabetes model is
insulin deficient and likely to exhibit a reduced ability to efficiently
use glucose as an energy source. We therefore speculated that the
Figure 5. Echocardiography analysis was followed up to 6 weeks of reperfusion to examine the chronic effects of IR injury. VEH mice
developed a mild LV dilation as evidenced by a significant increase in LVEDV(A) and a tendency to increase LVESV(B). On the contrary, STZ mice
developed concentric hypertrophy as shown by decreased LVEDV, LVESV and increased EF (A,B,C). M-mode image showing the increase in the LV wall
and decrease in interstitial space in STZ heart (D). The development of hypertrophy in STZ heart after IR was confirmed by calculating ration of LV wall
thickness/LV weight (E). * indicates that p,0.05 compared to Day0 of the same treatment group. **indicates that p,0.05 compared to VEH on the
same day post IR and (n$5).
doi:10.1371/journal.pone.0030450.g005
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decrease in overall cardiac performance in diabetic animals after
IR may be due to reduced ability of the heart to utilize glucose.
We observed using [18F]-FDG and PET scanning that STZ mice
show a significantly decreased level of cardiac glucose uptake
compared to non-diabetic mice after IR. With regard to correcting
this defect, it has been shown that stimulation of glucose
metabolism using pharmacological interventions improves the
degree of functional recovery after IR in both animals model and
humans [12,14,15,16,17].
Whereas glucose metabolism decreased, STZ animals exhibited
smaller infarct area and fewer TUNEL positive cells after 24 hours
of reperfusion. In order to identify a possible mechanism of STZ-
diabetes-induced protection against cardiomyocyte injury induced
by IR, the level of cardiac autophagy was examined. Autophagy
has been observed at elevated levels in the heart of patients or pigs
with cardiomyopathy [18,19,20] and is thought to play an
important role in the regulation of and the development of heart
failure [21,22,23,24] and the upregulation of autophagy during
ischemia has been shown to be beneficial to the heart [19,25,26].
During ischemia, autophagy reduces the level of apoptosis in the
heart by degrading proteins and organelles that are damaged and
harmful to the cell. The removal of damaged mitochondria is
especially important as this will prevent the release of pro-
apoptotic factors such as cytochrome c and ROS [23,27].
Autophagy also enhances the recycling of amino and fatty acids
to be used for energy source in conditions of energy shortage such
as ischemia [22,23,28]. In addition, insulin acting via mTOR is
known to inhibit autophagy [29,30] and in cardiac insulin receptor
knockout (CIRKO) mice, there is a constitutively activated level of
autophagy [31]. We believe our data indicates that short term
activation of autophagy, likely at least in part due to the lack of
insulin, in the STZ-diabetic mice may be beneficial in reducing the
number of apoptotic cells and infarct size induced by IR. Indeed,
Hill’s group have shown previously that using aortic constriction to
induce pressure overload also induced autophagy in the heart
which peaks at 72 hours, is maintained for at least 3 weeks, and
provides a protective influence on cardiomyocytes to promote
functional recovery [19,32].
Macrophage infiltration is known to aggravate IR injury [33,34]
and is a potentially important contributor to changes in cardiac
function after IR is local inflammation [35]. Macrophages are
recruited from circulation to the site of injury and act to initiate the
inflammatory response as well as clear debris and contribute to
wound healing [35]. Macrophage infiltration into the heart may
also be important in effective repair after IR injury as the recruited
macrophage participate in producing cytokines and growth factors
required for the proliferation of fibroblasts and vascularization
[35]. However, long term inflammation is known to induce
excessive collagen deposition in the heart and ultimately cause
heart failure [36,37]. Our data indicates that IR induced
macrophage recruitment in heart tissue but that the number of
infiltrating macrophages was not different between the non-
diabetic and diabetic groups after 24 hours of reperfusion.
We performed further echocardiography study on VEH and
STZ mice with and without IR over a period of 42 days to obtain
a clear understanding of temporal changes in cardiac function.
Through this time-course analysis, we observed that VEH and
STZ hearts responded differently to IR. IR injury induces a
volume overload to the left ventricle and the heart normally
compensates for this by mechanically increasing the left ventricle
cavity by dilating it [38]. At 42 days post IR, VEH heart showed
an increase in LVEDV indicating the development of a mild LV
dilation. However on the contrary, STZ animals developed
concentric hypertrophy with a decrease in LV volume and
intraventricular space and an increase in LV wall thickness. We
hypothesized that the STZ heart differently compensate after IR
injury by increasing the LV mass as its cavity dilation may have
been limited by the excessive accumulation of collagen in the left
ventricle of the STZ mice. Indeed, pre-existing fibrosis may be
able to prevent dilation of the heart [39] and we observed that IR
injury caused a significant increase in the amount of collagen
deposition in the remote area, particularly in STZ-diabetic mice.
This is also in agreement with established literature indicating that
diabetes is associated with enhanced cardiac fibrosis [40,41,42].
Our data also indicated that diabetes alone for up to 42 days after
sham surgery had no significant effect on the development of
Figure 6. The degree of cardiac fibrosis was accessed by staining collagen using Masson Trichrome method. Quantification of the
collagen area over the total area revelaed that IR causes the development of fibrosis in both VEH and STZ heart but the degree of fibrosis is
significantly greater in STZ animal (A). Representative image from each group (B). The blue area represents fibrillar collagen. n$5 and * indicates that
p,0.05 compared to sham of the same treatment group. ** indicates that p,0.05 compared to VEH IR.
doi:10.1371/journal.pone.0030450.g006
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fibrosis. Thus, IR injury may have accelerated or enhanced the
effects of diabetes on accumulation of collagen in the heart. It is
well known that the hemodynamic and neurohormonal changes in
the period after MI stimulate events such as intense activation of
both the circulating and the local renin-angiotensin-aldosterone
system [43]. It has also been reported that diabetes is coupled with
an activation of the renin-angiotensin system in the heart [44].
Subsequent reactive and progressive interstitial fibrosis in the heart
have been shown to be highly related with elevated antiogensin II
and aldosterone. Pathologic changes such as this can induce left
ventricular hypertrophy and account for abnormal myocardial
stiffness and ventricular dysfunction [45]. Therefore, we suggest
that a combination of impaired glucose metabolism and excessive
consequences of neurohormonal activation after IR injury would
be a possible cause of more severe myocardial fibrosis in diabetic
mice.
The higher prevalence of heart failure after MI in diabetic
patients [46] can be explained by different chronic cardiac
remodeling and fibrosis confirmed in this study. Furthermore, the
valsartan in acute myocardial infarction (VALIANT) large scale
clinical study of 15,000 patients, used echocardiographic data to
clearly demonstrate the existence of the two cardiac hypertrophic
responses after IR injury [47,48]. Concentric hypertrophy was
associated with a worse prognosis, higher degree of morbidity and
mortality than dilated (eccentric) hypertorophy. Our study also
showed that STZ group developed concentric hypertrophy in
response to IR injury over time whereas VEH mice responded
differently and developed mild LV dilated hypertrophy. Although
we did not examine heart failure and mortality at much later time
points, the VALIANT findings correlate with the worse prognosis
we observed in STZ diabetic mice.
In conclusion, we have demonstrated here that STZ-diabetes
confers differential effects on cardiac remodeling events after IR
injury (figure 7). Diabetic mice show a smaller infarct area post-
MI, which may be the result of upregulated autophagy in the heart
of these animals. However, in diabetic mice glucose metabolism is
compromised at this time. Long term follow up studies indicated
that diabetic mice heart develop severe fibrosis and concentric
hypertophy leading to detrimental effects on functional perfor-
mance.
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